Article

Durable Response of Induction Sequential Chemotherapy Combined With Nimotuzumab and Consolidative Carbon Ion Radiotherapy With Non-V600 BRAF Mutation Locally Advanced Pancreatic Cancer

2021-08-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Pancreatic cancer remains a highly fatal malignancy among the most common cancers. Multidisciplinary systemic treatment is the vital method to prolong the survival of patients with locally advanced and advanced disease. <bold>Case presentation: </bold>We report a patient presented to the hospital with upper abdominal pain with occasional diarrhea for 6 months, d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 45e84517-a8be-5d0e-a193-5d5f484d85a8
DOI: 10.21203/rs.3.rs-809969/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Durable Response of Induction Sequential Chemotherapy Combined With Nimotuzumab and Consolidative Carbon Ion Radiotherapy With Non-V600 BRAF Mutation Locally Advanced Pancreatic CancerDOI 10.21203/rs.3.rs-809969/v1Read

Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudySemantic proximity Read

First Reported Advanced Pancreatic Cancer With Hyperprogression Treated With PD-1 Blockade combined with chemotherapy: A Case Report And Literature ReviewSemantic proximity Read

Nomogram to predict survival of patients with advanced and metastatic pancreatic cancerSemantic proximity Read

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of LiteraturesSemantic proximity Read

Systemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy.Semantic proximity Read

Consortium bibliometric analysis of hotspots and frontiers of immunotherapy in pancreatic cancerSemantic proximity Read

Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.Semantic proximity Read

Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line TherapySemantic proximity Read

Metastatic Pancreatic Cancer Now in Remission: A Case Report and Literature ReviewSemantic proximity Read

Intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial (METAPANC)Semantic proximity Read

PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read

Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.Semantic proximity Read